These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25667128)
1. Survivorship after allogeneic transplantation-management recommendations for the primary care provider. Tichelli A; Rovó A Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128 [TBL] [Abstract][Full Text] [Related]
2. Late effects after hematopoietic stem cell transplantation--critical issues. Tichelli A; Rovó A; Socié G Curr Probl Dermatol; 2012; 43():132-49. PubMed ID: 22377926 [TBL] [Abstract][Full Text] [Related]
3. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation. Cheon J; Lee YJ; Jo JC; Kweon K; Koh S; Min YJ; Park SH; Lee SH; Kim HJ; Choi Y Support Care Cancer; 2021 Feb; 29(2):975-986. PubMed ID: 32556712 [TBL] [Abstract][Full Text] [Related]
4. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Gifford G; Sim J; Horne A; Ma D Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824 [TBL] [Abstract][Full Text] [Related]
5. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Majhail NS; Rizzo JD Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238 [TBL] [Abstract][Full Text] [Related]
6. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957 [TBL] [Abstract][Full Text] [Related]
7. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
8. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396 [TBL] [Abstract][Full Text] [Related]
9. Late complications after hematopoietic stem cell transplantation. Tichelli A; Rovó A; Passweg J; Schwarze CP; Van Lint MT; Arat M; Socié G; Expert Rev Hematol; 2009 Oct; 2(5):583-601. PubMed ID: 21083023 [TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
11. High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink? Mohty M; Malard F; Savani BN Biol Blood Marrow Transplant; 2015 Apr; 21(4):620-4. PubMed ID: 25246296 [TBL] [Abstract][Full Text] [Related]
12. Sexual health in hematopoietic stem cell transplant recipients. Li Z; Mewawalla P; Stratton P; Yong AS; Shaw BE; Hashmi S; Jagasia M; Mohty M; Majhail NS; Savani BN; Rovó A Cancer; 2015 Dec; 121(23):4124-31. PubMed ID: 26372459 [TBL] [Abstract][Full Text] [Related]
13. Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Tichelli A; Rovó A; Gratwohl A Hematology Am Soc Hematol Educ Program; 2008; ():125-33. PubMed ID: 19074070 [TBL] [Abstract][Full Text] [Related]
18. What do we need to know about allogeneic hematopoietic stem cell transplant survivors? Clark CA; Savani M; Mohty M; Savani BN Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688 [TBL] [Abstract][Full Text] [Related]
19. Adverse Late and Long-Term Treatment Effects in Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors. Mosesso K Am J Nurs; 2015 Nov; 115(11):22-34; quiz 35. PubMed ID: 26473441 [TBL] [Abstract][Full Text] [Related]
20. Complications of allogeneic hematopoietic stem cell transplantation. Arnaout K; Patel N; Jain M; El-Amm J; Amro F; Tabbara IA Cancer Invest; 2014 Aug; 32(7):349-62. PubMed ID: 24902046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]